Title:
EGFRおよびIGF-IRに対するナノボディおよびポリペプチド
Document Type and Number:
Japanese Patent JP2009511032
Kind Code:
A
Abstract:
The invention relates to polypeptides and Nanobodies against Epidermal Growth Factor Receptor (EGFR) and/or Insulin Growth Factor-I Receptor (IGF-IR). The invention also relates to nucleic acids encoding such Nanobodies and polypeptides; to methods for preparing such Nanobodies and polypeptides; to host cells expressing or capable of expressing such Nanobodies or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such Nanobodies, polypeptides, nucleic acids and/or host cells; and to uses of such Nanobodies, polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes.
Inventors:
Lalemans,tone
De harto, hans
Hogen Boom, Hendrick, Renellas, Jacobs, Matthew
De harto, hans
Hogen Boom, Hendrick, Renellas, Jacobs, Matthew
Application Number:
JP2008534933A
Publication Date:
March 19, 2009
Filing Date:
October 11, 2006
Export Citation:
Assignee:
Abrinks En.
International Classes:
C12N15/09; A61K39/395; A61K48/00; A61K51/00; A61P11/12; A61P17/06; A61P19/02; A61P29/00; A61P35/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02
Attorney, Agent or Firm:
Takashi Shoji
Yuriko Shinobu
Takuya Osugi
Aki Soga
Yuriko Shinobu
Takuya Osugi
Aki Soga